You are in the accessibility menu

Please use this identifier to cite or link to this item: http://acervodigital.unesp.br/handle/11449/117651
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCampos, Cecilia Bonolo de-
dc.contributor.authorNunes, Fernanda Camargo-
dc.contributor.authorLavalle, Gleidice Eunice-
dc.contributor.authorCassali, Geovanni Dantas-
dc.date.accessioned2015-03-18T15:56:38Z-
dc.date.accessioned2016-10-25T20:35:52Z-
dc.date.available2015-03-18T15:56:38Z-
dc.date.available2016-10-25T20:35:52Z-
dc.date.issued2014-09-01-
dc.identifierhttp://iv.iiarjournals.org/content/28/5/863.full-
dc.identifier.citationIn Vivo. Athens: Int Inst Anticancer Research, v. 28, n. 5, p. 863-866, 2014.-
dc.identifier.issn0258-851X-
dc.identifier.urihttp://hdl.handle.net/11449/117651-
dc.identifier.urihttp://acervodigital.unesp.br/handle/11449/117651-
dc.description.abstractBackground/Aim: Feline mammary carcinomas (FMCs) are characterized by poor prognosis and little progress has been made in extending patient survival. The aim of the study was to compare overall survival periods of FMCs submitted to different treatment protocols, including surgery and adjuvant chemotherapy. Materials and Methods: Analysis of conventional surgical excision alone or in association with adjuvant chemotherapy with carboplatin in sixteen cats diagnosed with stage III and grade II or III FMCs was performed. Results: Patients treated with surgery and chemotherapy presented a longer overall survival (OS) than those treated only with surgery, however, no statistical difference was observed when comparing both treatments (p=0.883). Conclusion: Therapeutic benefit of carboplatin remains invalidated for FMCs and further investigation regarding adjuvant therapies are warranted. Surgery remains as the gold treatment in FMCs.en
dc.description.sponsorshipFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)-
dc.description.sponsorshipFundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG)-
dc.description.sponsorshipConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)-
dc.description.sponsorshipCoordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)-
dc.format.extent863-866-
dc.language.isoeng-
dc.publisherInt Inst Anticancer Research-
dc.sourceWeb of Science-
dc.subjectFelineen
dc.subjectmammary glanden
dc.subjectneoplasmen
dc.subjectchemotherapyen
dc.subjectcarboplatinen
dc.titleUse of surgery and carboplatin in feline malignant mammary gland neoplasms with advanced clinical stagingen
dc.typeoutro-
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)-
dc.contributor.institutionUniversidade Federal de Minas Gerais (UFMG)-
dc.description.affiliationSao Paulo State Univ FCAV UNESP, Sch Agr & Vet Sci, Postgrad Program Vet Med, Jaboticabal, Brazil-
dc.description.affiliationFed Univ Minas Gerais UFMG, Biol Sci Inst ICB, Dept Gen Pathol, Lab Comparat Pathol, Belo Horizonte, MG, Brazil-
dc.description.affiliationFed Univ Minas Gerais UFMG, Sch Vet, Vet Hosp, Dept Vet Clin & Surg, Belo Horizonte, MG, Brazil-
dc.description.affiliationUnespSao Paulo State Univ FCAV UNESP, Sch Agr & Vet Sci, Postgrad Program Vet Med, Jaboticabal, Brazil-
dc.identifier.wosWOS:000341281900024-
dc.rights.accessRightsAcesso restrito-
dc.relation.ispartofIn Vivo-
Appears in Collections:Artigos, TCCs, Teses e Dissertações da Unesp

There are no files associated with this item.
Show simple item record Show full item record   View Statistics
 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.